Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By activating these receptors, https://adreaymbf037766.aioblogs.com/89058991/tirzepatide-a-promising-new-treatment-for-obesity